Why Does Doxycycline Pose a Relatively Low Risk for Promotion of Clostridioides difficile Infection?

BACKGROUND: Clinical studies suggest that doxycycline poses a low risk for promotion of Clostridioides difficile infection, but the microbiologic explanation for this finding is unclear. METHODS: Mice treated with oral doxycycline, oral azithromycin, subcutaneous ceftriaxone, doxycycline plus ceftri...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Dongyan, Mana, Thriveen S.C., Cadnum, Jennifer L., Deshpande, Abhishek, Afsari, Faezeh, Sangwan, Naseer, Donskey, Curtis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pathogens and Immunity 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254868/
https://www.ncbi.nlm.nih.gov/pubmed/35800258
http://dx.doi.org/10.20411/pai.v7i1.512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254868/
https://www.ncbi.nlm.nih.gov/pubmed/35800258
http://dx.doi.org/10.20411/pai.v7i1.512

Ejemplares similares